V-Bio invests into ExeVir Bio to accelerate development of new treatment conferring broad protection against Covid-19
Ghent, Belgium, 28 July 2020 – Today V-Bio Ventures announces its investment in a EUR 23 million Series A financing into ExeVir Bio. […] July 28, 2020 · Turnstone CommunicationsAnacura, a Belgian biotech company, sells stem cell business to Boehringer Ingelheim
Ghent, Belgium, 27 July 2020 – GST, the stem cell specialist for horses and pets within the Anacura Group, has […] July 27, 2020 · Turnstone Communications
Article
VIB: the driving force behind a booming biotech ecosystem
Since VIB was established, the world class research institute has been led by a duo of managing directors. As Johan […] July 7, 2020 · BioVox
Article
The opioid epidemic: solutions to a painful problem
This article was authored by Rishabh Chawla from V-Bio Ventures. Opioid misuse is a public health crisis that has resulted […] July 7, 2020 · V-Bio Ventures
Article
Colorectal cancer discovery raises hope for microbiome treatment
A new mechanism causing colorectal cancer has been discovered by researchers from VIB and Ghent University. A specific protein was […] July 7, 2020 · BioVoxMax Planck researchers feed Proteome AI with PharmaFluidics technology
Micro-chip based µPAC™ LC columns – key component in NATURE study doubling the universe of known proteins across all kingdoms […] June 18, 2020 · Turnstone Communications
Article
To prevent another pandemic, we need to improve our relationship with animals
The new coronavirus did not come as a bolt from the blue. For many years, the World Health Organization (WHO) […] June 8, 2020 · BioVox
Article
How changing diets gave rise to the world’s deadliest diseases
This article was authored by Ward Capoen from V-Bio Ventures. In a recent article, we discussed how the most prescribed […] June 8, 2020 · V-Bio Ventures
Article
Fundamental research leads to treatment breakthrough in rare genetic diseases
A basic research breakthrough is improving patient lives, as researchers realized their rare genetic condition could be treated by repurposing […] June 8, 2020 · BioVox
Article
Talking T cells with David Masopust
Immunology is a complex but vitally important branch of the life sciences. Earlier this year, we attended a Keystone Symposia […] June 8, 2020 · BioVoxPharmaFluidics awarded VLAIO research grant
Funding will support product range extension of micro-chip based µPAC™ nano, capillary and microflow LC columns, and accelerated development of […] June 2, 2020 · Turnstone Communications
Article
Onno van de Stolpe talks Belgian biotech
At this year’s Innovation for Health, we sat down for a chat with Onno van de Stolpe. Winner of the […] May 5, 2020 · BioVox
Article
Cell therapies: opportunities and challenges
This article was authored by Christina Takke from V-Bio Ventures. Recent activities in the cell therapy field have prompted many […] May 5, 2020 · V-Bio Ventures
Article
TheSocialMedwork: equal access to medicines for everyone, everywhere
We recently sat down with Sjaak Vink, the visionary entrepreneur behind TheSocialMedwork. This enterprise gives patients all over the world […] May 5, 2020 · BioVox
Article
Belgian clinical trials for COVID-19
With COVID-19 cases soaring into the millions, and a vaccine still a ways off, patients are desperate for a treatment. […] May 5, 2020 · BioVoxBioVox: the global network for Belgian life sciences turns five and launches a new website!
May 4, 2020 · Turnstone Communications
Article
Potential impact of the corona crisis on the life sciences industry
This article was authored by Christina Takke from V-Bio Ventures Over the past few months, every news headline has focused […] March 26, 2020 · V-Bio Ventures
Article
University Hospital Ghent and VIB are testing medication to treat COVID-19-associated respiratory illness
University Hospital Ghent and VIB are assessing a drug called Leukine® to treat patients with respiratory illness associated with COVID-19. Major medical centers in [...] March 25, 2020 · BioVoxBiogazelle initiates large-scale testing of COVID-19 in Belgium
Ghent, Belgium, April 2, 2020 – Biogazelle NV, a CRO specialized in RNA analytics, has announced the initiation of large-scale testing of patient samples for SARS-CoV-2. [...] April 2, 2020 · Turnstone Communications
News
ElmediX wants to stop coronavirus by heating patients in a controlled manner
Mechelen, Belgium, 24 March 2020 – The coronavirus has brought the whole world to a standstill. The Belgian company ElmediX wants to contain the virus with intensive [...] March 24, 2020 · Turnstone Communications
Article
Janssen Pharmaceutica and Filliers Distillery make disinfectant hand gel
Pharmaceutical company Janssen Pharmaceutica and gin distillery Filliers Distillery are making disinfectant hand gel from Sunday. They will distribute it among the Belgian hospitals. March 24, 2020 · Janssen Pharmaceutica
Article
Professors of Product Development from UAntwerp are looking at emergency production of mouth masks
At the University of Antwerp, twelve product developers are working day and night to develop oral masks. “Together with industrial partners, we try to set up an [...] March 24, 2020 · BioVox
Article
The long-distance race for a corona vaccine
Developing a vaccine takes a long time and occurs in different phases. A virus spreads quickly and unpredictably. Therefore, the outcome is a gamble for anyone in the race for the corona vaccine. March 24, 2020 · BioVox
Article
Gates Foundation commissions large coronavirus study from KU Leuven
The Bill & Melinda Gates Foundation is to provide samples of 15,000 therapeutic molecules to the Gasthuisberg hospital at the University of Leuven, to aid research into therapies to combat the coronavirus COVID-19, De Standaard reports. March 24, 2020 · BioVox
Article
VIB achieves important milestone in the development of a COVID-19 drug
Earlier this year, the lab of Xavier Saelens (VIB-UGent) announced the discovery of a unique antibody that is capable of binding the virus that causes COVID-19 (SARS-CoV-2). [...] March 24, 2020 · BioVox
Article
Augustine Therapeutics: bridging the valley of death with VIB Discovery Sciences
Augustine Therapeutics is one of VIB’s latest spinoffs, developing a first-in-class drug for Charcot-Marie-Tooth disease. The company recently announced a seed-funding [...] February 26, 2020 · V-Bio Ventures
Article
Why everyone needs to be a part of the CRISPR conversation
With the soaring cost of drugs for rare indications, many biotech and pharmaceutical companies are focusing R&D efforts on orphan diseases. Will the pendulum swing back towards more common maladies? February 26, 2020 · BioVox
Article
Belgian initiatives boosting animal-free innovation
Animals have been used throughout history to understand human physiology and to resolve scientific questions related to health and disease. Nowadays, however, both scientists [...] February 26, 2020 · BioVoxMontis Biosciences launched with €8.4 million seed financing and a novel approach to immuno-oncology
Montis Biosciences announces its launch with €8,4 million in seed financing from an international investor syndicate to investigate interactions between perivascular macrophages [...] February 20, 2020 · Turnstone Communications
Sponsored
Inari: shaking things up in the agriculture business
Inari Agriculture has been awarded the 2020 Newcomer of the Year Trophy by Flanders Investment & Trade (FIT). Inari (US) opened its first foreign R&D branch in Ghent’s biotech [...] February 12, 2020 · Turnstone CommunicationsPharmaFluidics announces product range extension for its µPACᵀᴹ chromatography chips to serve new biopharma markets
PharmaFluidics NV, an innovative player in the field of analytical chromatography, announces a product range extension into capillary flow rate liquid chromatography (capillary LC). [...] February 10, 2020 · Turnstone Communications
Article
Predictions for Belgian Biotech in 2020
With the Belgian biotech landscape blooming, BioVox reached out to some of the investors in our network to see what their predictions are for the coming year. From trends to companies to keep an eye on, here’s their take on 2020! January 22, 2020 · BioVox
Article
Battling antibiotic resistance: new strategy targets bacterial slime
Researchers have developed a new antibacterial strategy that weakens bacteria by preventing them from cooperating. The method involves attacking the protective biofilm [...] January 22, 2020 · BioVox
Article
Signposts inspired by bat sonar improve self-driving robots
To improve sonar navigation systems used by self-driving robots, researchers from Belgium, The Netherlands and Germany have turned to nature for an ingenious solution. [...] January 22, 2020 · BioVoxV-Bio Ventures invests in RootWave in a EUR 6.5 M Series A financing to develop and market electrical weed killing solutions
Today V-Bio Ventures announces its investment in RootWave, a pioneer in electrical weed killing solutions. RootWave secured ca. EUR 6.5m in a Series A investment round [...] January 20, 2020 · V-Bio Ventures
Article
How business models shaped our current drug development trends
December 17, 2019 · V-Bio VenturesV-Bio Ventures invests in Augustine Therapeutics, a VIB and KU Leuven spin-off to fight neuromuscular diseases
Ghent, Belgium, December 16 2019 – Today V-Bio Ventures announces its investment in Augustine Therapeutics, a new venture developing innovative […] December 16, 2019 · V-Bio Ventures
Article
New immune system gene discovered in a Flemish boy
Researchers studying a rare disease have identified a new gene responsible for human immune system regulation. An international collaboration combined […] November 26, 2019 · BioVox
Article
Could tick saliva help save lives?
The biotech Bioxodes is using a molecule derived from tick saliva to stop blood clots. The Walloon company is focused […] January 23, 2020 · BioVox
Article
Magic mushrooms in modern medicine
This article was authored by Katja Rosenkranz from V-Bio Ventures. More than 75 years after the initial discovery of lysergic acid […] November 26, 2019 · V-Bio VenturesCaelus Health and Nestlé Health Science sign exclusive global development & option agreement on Caelus’ microbiome-based food supplements
PRESS RELEASE Amsterdam/Beerse, November 25, 2019 – Caelus Health, which develops food supplements and pharmaceutical products for the prevention, early […] November 25, 2019 · BioVox
Article
Combining disciplines for a simple sampling solution
Novosanis have been able to achieve great success with their clever yet simple urine sampling solution Colli-Pee® [...] November 25, 2019 · BioVox
Sponsored
Pulsify Medical to develop a wearable heart monitor patch
Pulsify Medical, a joint imec and KU Leuven spin-off, has closed a seed funding round of €2.6 million. The investment, […] October 24, 2019 · Turnstone Communications
Sponsored
A bridge from east to west: linking Chinese investors with European companies
There are two main reasons why a European company might want to establish official links with a Chinese investor: funding, […] October 24, 2019 · Turnstone Communications
Article
The 2019 Nobel Prize in Medicine: How do cells adapt to changing oxygen levels?
The 2019 Nobel Prize in Physiology or Medicine was awarded to William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza. Their discoveries have [...] October 24, 2019 · BioVox
Article
Mining the microbiome for sustainable agriculture solutions
In this month’s article we take a look at Aphea.Bio, a V-Bio Ventures portfolio company. This startup is developing microbiome […] October 24, 2019 · V-Bio VenturesOvizio Imaging Systems announces iLine F and BioConnect supply agreements with Celgene Corporation
Brussels, Belgium 22/10/2019 – Ovizio Imaging Systems, a company providing an innovative microscopic imaging technology to the bioprocessing market, today […] October 22, 2019 · Turnstone CommunicationsProf. Matthias Mann joins PharmaFluidics Advisory Board
Ghent, Belgium – October 22, 2019 – PharmaFluidics NV, an innovative player in the field of proteomics with the unique high-resolution µPACTM micro-Chip chromatography products, is pleased to welcome Prof. Dr. Matthias Mann as member of its Advisory Board. October 22, 2019 · Turnstone CommunicationsPulsify Medical, a joint imec and KU Leuven spin-off, closes first-round funding, led by imec.xpand
Pulsify Medical will develop wearable ultrasound patches for non-invasive, real time monitoring of physiological parameters inside the body Leuven, Belgium, […] October 14, 2019 · Turnstone Communications
Article
Closing the gender gap in biotech funding: a follow-up study
This article was authored by Christina Takke from V-Bio Ventures. In this follow-up to a previous VC Views article, V-Bio […] September 24, 2019 · V-Bio Ventures
Article
HIV breakthrough at UZ Gent leads to new hope for a cure
When patients take HIV medication, a small amount of the virus nonetheless stays hidden in the body, preventing a cure. […] September 23, 2019 · BioVox
Article
Three business strategy tips to help your company grow
Turnstone Communications, the driving force behind BioVox news, is a consultancy agency catering to life sciences companies. Lending a hand […] September 23, 2019 · BioVox
Sponsored
Fresh insights into the future of cell therapy
The first edition of Science for health was held in the heart of Brussels on September 11 with a focus […] September 23, 2019 · BioVoxGalapagos-Gilead billion-dollar deal: beyond the numbers
Last month, Galapagos sealed a 5-billion-dollar deal with Gilead. Now that the dust has started to settle, we’re taking a […] August 27, 2019 · BioVox
Sponsored
Why events are important for creating connections in the life sciences
Collaboration is vital for science. Without cross-pollination of ideas and talent, progress would be excruciatingly slow in both industry and academia. [...] August 27, 2019 · BioVox
Article
Meet the men who unraveled the mystery of protein folding
Franz-Ulrich Hartl and Arthur Horwich have been named the winners of the 2019 Dr. Paul Janssen Award for Biomedical Research. […] August 27, 2019 · Janssen Pharmaceutica
Article
The million-dollar question: How much do you charge for a lifesaving drug?
The newest generation of ground-breaking gene therapy drugs, Zolgensma and Zynteglo, come with eye-catching price tags [...] August 26, 2019 · V-Bio Ventures
Article
How do we reduce the high cost of clinical trials?
Drug development is an exorbitantly expensive endeavor. A large expense factor for developing a new therapy is the high cost of conducting clinical trials. [...] July 18, 2019 · V-Bio Ventures
Sponsored
Living on the edge: the challenge of doing things differently in cell therapy
Belgian company Celyad is a trailblazer in oncology: its T cell therapies based on NK receptors are cutting edge even […] July 17, 2019 · BioVox
News
Gilead and Galapagos enter into transformative research and development collaboration
Gilead to Make $3.95 Billion Upfront Payment and $1.1 Billion Equity Investment Gilead Gains Access to Galapagos’ Differentiated Drug Discovery […] July 15, 2019 · BioVox
Article
Solving food waste one StixFresh sticker at a time
Food waste is a major global issue exacerbated by premature fruit spoilage. A US company, StixFresh, is working together with VIB-KU Leuven Prof Patrick Van Dijck [...] July 15, 2019 · BioVox
Sponsored
WELBIO joins ranks with celebrities after a new bacterium is named after the institute
WELBIO has received a truly unique form of acknowledgement: a newly discovered bacterium has been named after the research institute. […] July 10, 2019 · Turnstone Communications
News
Confo Therapeutics and DyNAbind announce drug discovery collaboration to identify novel GPCR-modulating compounds
Ghent, Belgium, and Dresden, Germany – 3 July 2019 – Confo Therapeutics, an emerging drug discovery company, and DyNAbind GmbH […] July 3, 2019 · Turnstone Communications
Article
Edible antibodies to prevent and treat gut diseases
Belgian researchers have developed edible antibodies that can prevent gut bacterial infections. Normally antibodies need to be injected, but the […] June 27, 2019 · BioVox
Article
A new type of power plants to combat climate change
The prestigious organization EMBO recently announced several new members, including the appointment of VIB-UGent scientist Prof Wout Boerjan. Boerjan joins […] June 27, 2019 · BioVox
Article
Betting big on blood screens for early cancer detection
This article was authored by Ward Capoen from V-Bio Ventures. The American Society of Clinical Oncology (ASCO) just held their […] June 27, 2019 · V-Bio Ventures
Sponsored
Miracle microchips improving cell therapy manufacturing
A microchip engineer might seem like an odd fit for a keynote speaker at an event focused on cell therapy, but at Science for health Peter Peumans will [...] June 14, 2019 · BioVox
Sponsored
Confo Therapeutics: the next Belgian biotech star?
Just days before KBC Securities’ “State of the Union” announcement on how well Belgian biotech has been faring this year, […] May 29, 2019 · Turnstone Communications
Sponsored
The future of healthcare is digital
This month marked the crystal anniversary of the life sciences networking event Knowledge for Growth. The event was a huge […] May 29, 2019 · Turnstone Communications
Sponsored
Science for health: a new event for creating research connections
Science for health is Belgium’s new research event, set to promote more collaborations in our stellar life sciences ecosystem. The […] May 29, 2019 · BioVox
Article
OCTIMET Oncology tackling cancer with a new captain at the helm
In this article, V-Bio Ventures introduces one of their portfolio companies, OCTIMET. This Belgian oncology startup just added a new […] May 29, 2019 · V-Bio VenturesStellar year for Belgian biotech
Belgium has once again strengthened its position as Europe’s biotech leader. Today, Belgian biotech companies comprise 23 percent of the […] May 10, 2019 · BioVox
Article
Cultured meat, plant-based patties and bug burgers: VCs are backing protein alternatives
When it comes to food, our key sources of nutrition haven’t changed much in the last ten thousand years. Though hyped-up food trends and diets come and go, [...] April 16, 2019 · V-Bio Ventures
Sponsored
Holographic imaging technology shines a light on cells
Have you ever considered how scientists are able to count transparent cells in a see-through solution? Traditional methods involve dyes, microscopes, time and effort [...] April 9, 2019 · Turnstone Communications
Article
Deadly mosquitoes are invading Europe
Due to climate change, two species of tropical mosquitoes are spreading into Europe at increasing rates. Their presence is linked to a range of tropical viruses [...] April 3, 2019 · BioVox
Article
Hydrogen gas panel set to revolutionize clean energy production
Bioscience engineers at KU Leuven have created a record-breaking hydrogen gas panel. The panel is capable of producing 250 liters of hydrogen gas per day [...] March 27, 2019 · BioVox
Article
Closing the gender gap in biotech funding
Companies with a good gender balance consistently outperform those with only men in their management teams. [...] March 19, 2019 · V-Bio Ventures
Article
Battling antibiotic resistance: are we ready for a bacteriophage revival?
The discovery of antibiotics fundamentally changed healthcare in the 20th century. Deadly infections suddenly became treatable and millions of lives […] March 12, 2019 · BioVox
Article
Women in STEM: fixing the leaky pipeline
Happy International Women’s Day! This year, in honor of the day, we’ve decided to highlight an important and personal topic: […] March 8, 2019 · BioVox
Article
Orphan CNS diseases receive attention with new Minoryx site in Belgium
The Spanish start-up Minoryx Therapeutics recently opened a subsidiary in Belgium to further their research on treatments for rare and […] March 4, 2019 · BioVox
Article
Microbiome linked to depression in a groundbreaking Benelux study
The microbiome had been at the forefront of a lot of research and news in the past few years. Now, […] February 19, 2019 · BioVox
Article
Life after a PhD: alternatives to academia
This article was authored by Rishabh Chawla from V-Bio Ventures. Having finished a PhD in life sciences can often leave […] February 19, 2019 · V-Bio Ventures
Sponsored
From scientist to entrepreneur: how a Belgian chromatography company came to be
Pharmafluidics is a Belgian company rethinking the fundamentals of liquid chromatography. Introducing a fundamentally new type of stationary phase in […] February 12, 2019 · Turnstone CommunicationsAuXin Surgery Announces the Launch of its new CADISS System for Selective Dissection in Surgery
Louvain-la-Neuve, Belgium, 7 February 2019 – AuXin Surgery, a medical device company, announces that it has obtained CE Class III […] February 7, 2019 · Turnstone Communications
Sponsored
Inari’s agricultural revolution hits Europe with a new site in Ghent
Inari, a U.S. company revolutionizing agricultural R&D, have just opened up their first overseas office in Ghent, Belgium. Partnering with […] February 6, 2019 · Turnstone CommunicationsPharmafluidics’ new product launch steers ‘on-a-chip’ separations of complex biological samples to new heights
PharmaFluidics NV is a game-changing innovator in the field of analytical chromatography. The company has devised a fundamentally new way […] February 1, 2019 · Turnstone Communications
News
Biocartis raises EUR 55.50 million
Biocartis Group NV (the “Company” or “Biocartis”), an innovative molecular diagnostics company (Euronext Brussels: BCART), announces today that it successfully […] January 25, 2019 · BioVox
Article
Are we spending too much money on cancer drugs?
This article was authored by Ward Capoen from V-Bio Ventures. November is classically the month where immunotherapy takes center stage, […] January 22, 2019 · V-Bio Ventures
Article
New laser-based medical device revolutionizes cardiovascular disease diagnosis
Imec and Ghent University have developed a unique photonic-based medical device for the screening of arterial stiffness and the diagnosis […] January 16, 2019 · BioVox
Article
A microbiome solution for type 1 diabetes?
Few things unite us the way trying to help a sick child does. Children living with the burden of type […] December 14, 2018 · Janssen Pharmaceutica
Sponsored
Avoiding the pitfalls of clinical development as a biotech
For many decades, the pharmaceutical industry was the sole driver of innovation in healthcare. The rapid expansion of knowledge has […] December 11, 2018 · Turnstone Communications
Sponsored
argenx signs billion-dollar deal with Janssen
Another Belgian biotech on the up and up: argenx just closed a billion-dollar deal with Janssen Pharmaceutica for their antibody […] December 4, 2018 · Turnstone Communications
Article
A Personal Translation of Microbiome Futures
Nature Biotechnology published a thought-provoking piece addressing critical questions in the development of microbiome-based solutions focused on disease interception. Co-authored […] November 28, 2018 · Janssen Pharmaceutica
Article
Battling antibiotic resistance: a new protein powered solution
The discovery of antibiotics fundamentally changed healthcare in the 20th century. Deadly infections suddenly became treatable and millions of lives […] November 27, 2018 · BioVoxIPBES to Launch Global Assessment Report on Biodiversity and Ecosystem Services
19 November 2018 – Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services (IPBES) to Launch First Global Assessment Report […] November 21, 2018 · BioVox
Article
Why start-ups can become mega companies in the pharma sector
In a previous BioVox article, we analyzed the steps needed for a life sciences start-up to turn into a fully […] November 20, 2018 · V-Bio VenturesV-Bio Ventures leads Camel-IDS EUR 37m Series A financing
15 November 2018, Ghent (Belgium) – V-Bio Ventures leads Camel-IDS EUR 37m Series A financing to develop cancer targeted radiopharmaceuticals Camel-IDS […] November 15, 2018 · V-Bio VenturesMithra Announces the Completion of its Lead Clinical Phase III Programme for Estelle
14 Nov 2018 – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces the completion of the […] November 14, 2018 · BioVox
Sponsored